APA (7th ed.) Citation

Seelig, J., Heller, R., Haubruck, P., Sun, Q., Klingenberg, G. J., Hackler, J., . . . Biglari, B. (2021). Selenium-binding protein 1 (SELENBP1) as biomarker for adverse clinical outcome after traumatic spinal cord injury. Frontiers in neuroscience, 15, . https://doi.org/10.3389/fnins.2021.680240

Chicago Style (17th ed.) Citation

Seelig, Julian, et al. "Selenium-binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury." Frontiers in Neuroscience 15 (2021). https://doi.org/10.3389/fnins.2021.680240.

MLA (9th ed.) Citation

Seelig, Julian, et al. "Selenium-binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury." Frontiers in Neuroscience, vol. 15, 2021, https://doi.org/10.3389/fnins.2021.680240.